Study to Evaluate the Safety of AT2220 in Pompe Disease - Related Studies

Study to Evaluate the Safety of AT2220 in Pompe Disease

This study is currently recruiting participants.

Study NCT00688597. Last updated on November 19, 2008. Information provided by Amicus Therapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pompe Disease

2	Additional conditions recognized in this trial
		Glycogen Storage Disease Type II

3	More general conditions related to this trial
		Brain Diseases
		Brain Diseases, Metabolic
		Brain Diseases, Metabolic, Inborn
		Carbohydrate Metabolism, Inborn Errors
		Central Nervous System Diseases
		Genetic Diseases, Inborn
		Glycogen Storage Disease
		Lysosomal Storage Diseases
		Lysosomal Storage Diseases, Nervous System
		Metabolic Diseases
		Metabolism, Inborn Errors
		Nervous System Diseases

4	Interventions listed in this trial
		AT2220

5	Sponsors listed in this trial
		Amicus Therapeutics